Chronic activation of ORL1 receptor induces supersensitization of adenylyl cyclase

R Y Chan1, Y H Wong

  • 1Department of Biology and the Biotechnology Research Institute, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon.

Neuroreport
|November 5, 1999
PubMed

Insights

Chronic activation of the opioid receptor-like (ORL1) receptor causes cellular tolerance by inducing adenylyl cyclase (AC) supersensitization. This Gi/Go protein-mediated effect was observed in both cell lines expressing ORL1 receptors and those with endogenous ORL1 receptors.

Area of Science:

  • Pharmacology
  • Cellular Biology
  • Neuroscience

Background:

  • Opioid receptors and opioid receptor-like (ORL1) receptors share effector pathways.
  • Cellular tolerance to opioids involves adenylyl cyclase (AC) supersensitization.
  • The ORL1 receptor's role in cellular tolerance is not fully understood.

Purpose of the Study:

  • To investigate whether chronic ORL1 receptor activation induces AC supersensitization.
  • To determine the involvement of G-proteins in ORL1-mediated cellular adaptations.

Main Methods:

  • Established a HEK293 cell line stably expressing the human ORL1 receptor (293/ORL1).
  • Treated 293/ORL1 cells with nociceptin/OFQ and measured AC activity.
  • Utilized pertussis toxin to assess the role of Gi/Go proteins.
  • Examined endogenous ORL1 receptor activation in SK-N-SH neuroblastoma cells.

Main Results:

  • Chronic nociceptin/OFQ treatment of 293/ORL1 cells led to enhanced forskolin-stimulated AC activity.
  • This AC supersensitization was inhibited by pertussis toxin, implicating Gi/Go proteins.
  • Chronic activation of endogenous ORL1 receptors in SK-N-SH cells also resulted in Gi/Go-mediated AC supersensitization.

Conclusions:

  • Chronic ORL1 receptor activation induces cellular tolerance via AC supersensitization.
  • The observed AC supersensitization is mediated by Gi/Go proteins.
  • These findings highlight a conserved mechanism of cellular adaptation for both opioid and ORL1 receptors.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...